Aurora Cannabis Reaffirms FY24 Positive EBITDA, Plans Share Consolidation

TL;DR

**Aurora's aiming for profit and positive cash flow, but watch out for that share consolidation!**

AI Summary

Aurora Cannabis Inc. (NASDAQ: ACB) announced on January 31, 2024, that it expects to achieve positive annual Adjusted EBITDA for fiscal year 2024 and positive free cash flow in calendar year 2024. The company also revealed its intention to consolidate common shares, a move often made to increase share price and maintain NASDAQ listing requirements. This matters to investors because positive EBITDA and free cash flow signal improved financial health, while a share consolidation could impact share price and ownership structure.

Why It Matters

This filing indicates Aurora Cannabis is making progress towards profitability and financial stability, which could boost investor confidence, but the share consolidation could dilute existing shareholders if not handled carefully.

Risk Assessment

Risk Level: medium — While positive EBITDA and free cash flow are good signs, the share consolidation introduces uncertainty regarding its impact on share price and investor sentiment.

Analyst Insight

An investor should monitor the details of the upcoming share consolidation and the Q3 earnings call on February 8, 2024, to understand the potential impact on their holdings and the company's financial trajectory, especially regarding the re-affirmed positive EBITDA and free cash flow expectations.

Key Players & Entities

• Aurora Cannabis Inc. (company) — the registrant and company providing the business update
• Glen Ibbott (person) — Chief Financial Officer who signed the report
• January 31, 2024 (date) — date of the news release and filing
• February 8, 2024 (date) — date of the Q3 2024 investor conference call
• fiscal 2024 (date) — period for which positive annual Adjusted EBITDA is expected
• calendar 2024 (date) — period for which positive free cash flow is expected

Forward-Looking Statements

• Aurora Cannabis will successfully achieve positive annual Adjusted EBITDA for fiscal 2024. (Aurora Cannabis Inc.) — medium confidence, target: March 31, 2024 (end of fiscal 2024)
• Aurora Cannabis will generate positive free cash flow in calendar 2024. (Aurora Cannabis Inc.) — medium confidence, target: December 31, 2024
• The share consolidation will lead to a temporary increase in Aurora Cannabis's stock price. (Aurora Cannabis Inc.) — medium confidence, target: Shortly after consolidation

FAQ

Filing Documents

• aurora_6k.htm (6-K) — 7KB
• ex991.htm (EX-99.1) — 18KB
• logo.jpg (GRAPHIC) — 11KB
• 0001279569-24-000088.txt ( ) — 41KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F Form 40-F SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated January 31, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Glen Ibbott Glen Ibbott Chief Financial Officer Date: January 31, 2024

View Full Filing

View this 6-K filing on SEC EDGAR